Skip to main content
. 2023 Jan;384(1):116–122. doi: 10.1124/jpet.121.001251

Fig. 1.

Fig. 1.

Heat-map illustrating the expression of circulating miRs in the indicated groups of patients. HFpEF, heart failure with preserved ejection fraction; Healthy, healthy control subjects; Empa, patients receiving empagliflozin; Met, patients receiving metformin; Ins, patients receiving insulin.